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The purpose of this paper was to report a successful treatment of transluminal Nd:YAG laser embolysis (NYE) for 
branch retinal artery occlusion (BRAO) with visible emboli. Two patients with acute, severe vision loss secondary 
to a branch retinal artery occlusion with visible emboli in one eye underwent NYE. A complete ocular examination 
was performed which included biomicroscopy of the posterior pole of the retina, intraocular pressure measurement, 
fundus color photographs, and fluorescein angiography (FA). After the NYE, the two patients showed dramatic im-
provements in best-corrected visual acuity, as well as, immediate and dramatic restorations in flow past the 
obstructed arteriole in FA. NYE is a treatment modality to be considered in patients with BRAO who present 
acutely with severe vision loss and a visible embolus.
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Branch retinal artery obstruction (BRAO) accounts for 
38% of acute retinal arterial obstructions.
1 BRAO usually 
results from emboli, although non- embolic causes such as 
vasculitides, coagulopathies, and vasospasms resulting from 
migraines and inflammatory conditions do occur. Emboli 
are visible on funduscopic examination in 62% of cases. 
Risk factors for BRAO development include hypertension, 
carotid occlusive disease or atherosclerosis, coronary 
artery disease, and hypercholesterolemia. Branch retinal 
artery obstructions typically occur at vessel bifurcations, 
and 98% of cases involve the temporal vessels.
2 There is no 
established effective treatment for BRAO. 
Recent studies indicated that Nd:YAG laser embolysis 
(NYE) treatment resulted in successful restoration of re-
tinal blood flow and improved best-corrected visual acuity 
(BCVA).
3,4 The present report describes outcomes following 
the treatment of two cases of BRAO with NYE.
Case Reports
Case 1
A 68-year-old woman presented with decreased visual 
acuity (VA), and 20 hours earlier had noticed a visual field 
defect in the superior half of her right eye. Her medical hist- 
ory was unremarkable except for a history of hyperlipidemia. 
BCVA was 20/63 at the initial examination. Slit lamp bio- 
microscopy and fundus examination revealed intraretinal 
edema with inferior retinal whitening in addition to a visible 
Hollerenhorst plaque. Fluorescein angiography (FA) rev- 
ealed an arterial filling defect along the inferotemporal arc- 
ade, distal to the corresponding embolus with foveal ischemia 
(Fig. 1). 
The initial treatment involved anterior chamber paracentesis, 
use of an IOP-lowering agent, and ocular massage. Appro-
ximately 12 hours later, BCVA of her right eye decreased 
to 20/200. A Goldmann three mirror lens was used to focus 
an Nd:YAG laser onto the arterial embolus. The laser energy 
level commenced at 0.5 mJ and was increased to 1 mJ (about 
12 pulses) until the embolus was partially or completely 
shattered. After shattering the embolus, a small amount of 
vitreous hemorrhage was noted inferior to the optic disc. 
Five days after treatment, FA showed no evidence of the 
emboli, and retinal arteriolar blood flow had been restored. 
BCVA improved to 20/80. At two months after NYE, BCVA 
was 20/25 with no remaining vitreous hemorrhage. At 
three months after NYE, BCVA was 20/20 and FA showed 
that the branch retinal artery and all arterioles were patent 
with good flow. At ten months after NYE, BCVA remained 
at 20/20, and there were no other complications.
Case 2
An 82-year-old woman presented with a four-day history Korean J Ophthalmol Vol.23, No.4, 2009
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Fig. 1. Color fundus photographs and fluorescein angiography (FA) showing branch retinal artery obstruction in case 1. (A) Color fundus 
photograph demonstrating an intraluminal embolus (arrow) and whitening of the retina along the inferior and temporal vascular arcades. in-
serted the asterisk panel ‘*’ shows a magnification of the embolus. (B) FA of the same patient showing obstructed blood flow at the site of the 
embolus and a downstream filling defect. (C) Color fundus photograph of the same patient taken five days after Nd:YAG laser embolysis 
(NYE). Note the small amount of vitreous hemorrhage around the disc. (D) Fluorescein angiography (FA) of the same patient five days after 
NYE showing perfusion at the site of the embolus and restoration of the downstream blood flow. (E) Color fundus photograph taken three 
months after NYE. There was no remaining vitreous hemorrhage. (F) FA at three months after NYE showing a patent retinal artery with good 
blood flow and no neovascularization.
of progressive decrease in VA in her left eye. Her medical 
history was unremarkable. At presentation, BCVA was 
20/200, which was lower than the reading of 20/32 taken six 
months earlier. Slit-lamp biomicroscopy revealed a large 
plaque in the associated branch retinal artery on the disc of 
the left eye. FA showed an arterial filling defect along the 
superotemporal arcade distal to the corresponding embolus 
(Fig. 2). A macular contact lens was used to deliver the 
Nd:YAG laser to the plaque. Pulsing commenced with one 
pulse at 0.5 mJ, and the energy was increased to 1 mJ, at 
which a total of eight pulses were applied to the plaque. 
A small amount of vitreous hemorrhage over the arteriole 
was noted which resulted in cessation of the laser treat- 
ment despite the remaining embolus. The following day, 
vitreous hemorrhage decreased slightly and laser treatment 
was recommenced (1 mJ×ten pulses). The large embolus 
was ruptured, and recirculation around the macula was noted. 
However, a partial embolus fragment remained in the asso-
ciated arteriole. On the second day after NYE, BCVA had 
improved to 20/100, and the vitreous hemorrhage remained 
present. On the third day after NYE, FA showed restoration 
of the retinal arteriolar blood flow. Forty days after NYE, 
BCVA had improved to 20/32. At four months after NYE, 
FA showed no retinal neovascularizations, and BCVA re-
mained at 20/32.
Discussion
Recent reports showed immediate restoration of retinal 
blood flow after NYE, in addition to rapid restoration of 
BCVA. However, complications such as vitreous hemorrhage 
and subretinal hemorrhage were observed.
3,4 In the present 
cases, laser treatment resulted in dramatic improvement in 
BCVA and restoration of retinal blood flow despite a small 
amount of vitreous hemorrhage.
Mason et al.
5 reported that visual prognosis after BRAO 
appeared to correlate with presenting VA, and that eyes with 
an initial VA of 20/40 or better usually remained at 20/40 
or better. Individuals with poor VA (e.g., 20/100 or worse) 
generally did not show significant improvement. They con-
cluded that it may be misleading to indicate that 80% of 
eyes with BRAO improve to 20/40 or better (as described in 
previous reports) when final BCVA is so closely related to 
presenting BCVA.
In conclusion, the presenting VA may be essential in de-
ciding whether to pursue aggressive treatment. Therefore, 
NYE should be considered an effective treatment in patients 
with BRAO with visible emboli.
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Fig. 2. Color fundus photographs and fluorescein angiography showing branch  retinal  artery obstruction  (BRAO) in Case 2. (A) Color fundus 
photograph six mon prior to BRAO. The asterisk panel ‘*’ shows a magnification of the disc and indicates no transluminal embolus. (B) Color 
fundus photograph showing a superior temporal branch retinal artery occlusion. Note the transluminal embolus (arrow) and opacification of the 
retina along the superior and temporal vascular arcades. The double asterisk panel ‘**’ shows a magnification of the transluminal embolus. (C) 
Fluorescein angiography (FA) showing the filling defect in the arteriole corresponding to the intraluminal embolus. (D) Color fundus photo-
graph taken three days after Nd:YAG laser embolysis (NYE). Note the small amount of vitreous hemorrhage around the disc. (E) FA three days 
after NYE showing restoration of retinal blood flow. (F) Color fundus photograph taken two mon after NYE. Note the spontaneous clearing of the 
small vitreous hemorrhage. (G) FA two mon after NYE showing a return of retinal blood flow.
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